V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240011435 | 240014197 | 1.74 | 53.25 | Palliative (P) | 2016-05-28 | 2016-05-28 | Bevacizumab | 2 | N | 240030247 | BEVACIZUMAB |
| 240011436 | 240012102 | 1.7 | 117 | Curative (C) | 2016-02-11 | 2016-03-03 | CHOP - 21 days | 02 | N | 240030251 | CHOP |
| 240011437 | 240012102 | 1.67 | 102.9 | Disease modification (D) | 2017-07-25 | 2017-07-28 | Methotrexate intrathecal | 2 | N | 240030251 | METHOTREXATE INTRATHECAL |
| 240011438 | 240007640 | 1.64 | 90.2 | Curative (C) | 2016-01-30 | 2016-12-31 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 240030254 | NOT MATCHED |
| 240011439 | 240007641 | 1.84 | 68 | Curative (C) | 2013-10-06 | 2013-10-06 | ALEMTUZUMAB + ETOPOSIDE + THIOTEPA | N | N | 240030263 | NOT MATCHED |
| 240011440 | 240007642 | null | null | Curative (C) | 2018-06-21 | 2018-06-29 | Trial Unspecified | 01 | N | 240030265 | TRIAL |
| 240011441 | 240007642 | 1.6 | 58.4 | Palliative (P) | 2014-08-31 | 2015-10-05 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 240030265 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011442 | 240007642 | 1.69 | 38.1 | Curative (C) | 2015-08-26 | 2015-10-15 | INTERLACE TRIAL | 02 | N | 240030265 | INTERLACE TRIAL |
| 240011443 | 240007643 | 1.59 | 98.7 | Curative (C) | 2014-09-17 | 2014-09-17 | INTERLACE TRIAL | N | null | 240030285 | INTERLACE TRIAL |
| 240011444 | 240015269 | 1.61 | 75 | Curative (C) | 2015-10-11 | 2015-10-11 | Methotrexate intrathecal | N | N | 240030296 | METHOTREXATE INTRATHECAL |
| 240011445 | 240015269 | 1.68 | 100 | Curative (C) | 2014-10-21 | 2014-10-21 | null | 02 | N | 240030296 | NOT MATCHED |
| 240011446 | 240007644 | 1.6 | 79.7 | Curative (C) | 2015-05-04 | 2015-05-04 | Methotrexate intrathecal | N | N | 240030321 | METHOTREXATE INTRATHECAL |
| 240011447 | 240012106 | 1.77 | 77 | Curative (C) | 2016-07-05 | 2016-11-29 | Methotrexate intrathecal | N | N | 240030322 | METHOTREXATE INTRATHECAL |
| 240011448 | 240012106 | 1.74 | null | Curative (C) | 2013-12-08 | 2013-12-15 | Azacitidine | N | N | 240030322 | AZACITIDINE |
| 240011449 | 240007647 | 1.58 | 70.4 | Palliative (P) | null | 2017-04-16 | Bevacizumab 15mg/kg | 02 | null | 240030325 | BEVACIZUMAB |
| 240011450 | 240007648 | null | 92.9 | Disease modification (D) | 2014-09-18 | 2014-09-18 | Azacitidine | N | N | 240030327 | AZACITIDINE |
| 240011451 | 240007650 | 1.69 | 0 | Palliative (P) | 2017-02-13 | 2017-03-25 | Bevacizumab | 02 | null | 240030332 | BEVACIZUMAB |
| 240011452 | 240007650 | 1.47 | 100.25 | Palliative (P) | 2018-11-14 | 2018-11-30 | Bevacizumab+Carbo+Pacliaxel | null | Y | 240030332 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011453 | 240007650 | 1.56 | null | Curative (C) | 2015-10-21 | 2016-02-13 | Trial Unspecified | N | N | 240030332 | TRIAL |
| 240011454 | 240007655 | 1.7 | null | Palliative (P) | 2018-10-17 | 2018-10-17 | BEVACIZUMAB + CARBO + PACLITAXEL | N | Y | 240030349 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011455 | 240007655 | 1.73 | 79.7 | Curative (C) | null | 2018-07-27 | Trial Unspecified | 99 | null | 240030349 | TRIAL |
| 240011456 | 240007659 | 1.75 | 58.8 | null | 2016-01-29 | 2016-02-17 | Azacitidine | 02 | N | 240030350 | AZACITIDINE |
| 240011457 | 240007660 | 1.66 | 45.9 | Curative (C) | 2013-06-25 | 2013-11-14 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 02 | N | 240030352 | NOT MATCHED |
| 240011458 | 240007662 | 1.8 | 87.9 | Disease modification (D) | 2014-10-25 | 2015-03-19 | Azacitidine | N | Y | 240030357 | AZACITIDINE |
| 240011459 | 240007663 | 1.7 | 86 | Palliative (P) | 2017-11-15 | 2017-11-20 | CARBOPLATIN | 02 | N | 240030374 | CARBOPLATIN |
| 240011460 | 240012114 | 1.65 | 80 | Curative (C) | null | 2014-12-07 | Trial Unspecified | N | N | 240030381 | TRIAL |
| 240011461 | 240007664 | 1.6 | 81 | null | 2015-03-09 | 2015-04-05 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 240030381 | PACLITAXEL |
| 240011462 | 240007664 | 1.53 | 11.1 | Curative (C) | 2013-02-24 | 2015-10-09 | null | 02 | Y | 240030381 | NOT MATCHED |
| 240011463 | 240007664 | 1.55 | 81.6 | Palliative (P) | null | 2017-11-10 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240030381 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011464 | 240007665 | 1.75 | 89.2 | Palliative (P) | 2013-03-29 | 2013-03-30 | Carboplatin AUC 2 - 5 | N | y | 240030413 | CARBOPLATIN |
| 240011465 | 240007666 | 1.84 | null | Curative (C) | 2014-02-01 | 2014-03-02 | Methotrexate intrathecal | 02 | N | 240030419 | METHOTREXATE INTRATHECAL |
| 240011466 | 240007668 | 1.78 | null | Curative (C) | 2014-08-10 | 2014-08-13 | CHOP | N | N | 240030419 | CHOP |
| 240011467 | 240007668 | 1.63 | 50.3 | Palliative (P) | null | 2014-06-19 | Bevacizumab 15mg/kg | 02 | N | 240030419 | BEVACIZUMAB |
| 240011468 | 240007670 | 1.7 | 78 | null | 2015-03-20 | 2015-04-09 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 240030437 | PACLITAXEL |
| 240011469 | 240014209 | null | null | Palliative (P) | null | 2013-09-15 | Bevacizumab | 02 | N | 240030451 | BEVACIZUMAB |
| 240011470 | 240007674 | 1.73 | 95 | Not known (9) | 2018-01-15 | 2018-08-01 | Trial Unspecified | 02 | N | 240030461 | TRIAL |
| 240011471 | 240007676 | 1.84 | 61.2 | Palliative (P) | 2016-06-20 | 2016-06-27 | Azacitidine | 02 | N | 240030464 | AZACITIDINE |
| 240011472 | 240012122 | 1.61 | 52.7 | Curative (C) | 2015-04-14 | 2015-05-07 | CHOP | N | N | 240030466 | CHOP |
| 240011474 | 240012123 | 1.57 | 106 | Curative (C) | 2017-02-19 | 2017-02-28 | Azacitidine | N | null | 240030469 | AZACITIDINE |
| 240011475 | 240007678 | 1.58 | 52 | null | 2014-07-20 | 2015-03-14 | null | 02 | N | 240030480 | NOT MATCHED |
| 240011476 | 240007678 | 1.59 | 52 | Palliative (P) | 2016-06-05 | 2016-07-06 | Bevacizumab | null | null | 240030480 | BEVACIZUMAB |
| 240011477 | 240007678 | 1.69 | null | Palliative (P) | null | 2016-09-28 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 240030480 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011478 | 240007679 | 1.81 | null | Palliative (P) | 2015-08-06 | 2015-08-26 | LI-1 TRIAL | 02 | Y | 240030493 | TRIAL |
| 240011479 | 240007680 | 1.75 | 60 | Curative (C) | 2015-09-26 | 2015-09-26 | null | 02 | N | 240030505 | NOT MATCHED |
| 240011480 | 240012127 | null | 102.6 | null | null | 2017-08-18 | Trial Unspecified | N | N | 240030507 | TRIAL |
| 240011481 | 240014213 | 1.91 | 83.9 | Curative (C) | 2016-07-17 | 2016-12-30 | INTERLACE TRIAL | 01 | N | 240030517 | INTERLACE TRIAL |
| 240011482 | 240014213 | 1.62 | 65.9 | Palliative (P) | 2014-03-08 | 2014-03-13 | Azacitidine | 02 | N | 240030517 | AZACITIDINE |
| 240011483 | 240014213 | null | 80.2 | Adjuvant (A) | 2016-08-21 | 2016-08-21 | INTERLACE TRIAL | 02 | N | 240030517 | INTERLACE TRIAL |
| 240011484 | 240007686 | 1.65 | 61.5 | Disease modification (D) | 2017-05-28 | 2017-05-29 | ALCL ALCL 99 Closed BM 1, 2 or 3 | 1 | N | 240030527 | NOT MATCHED |
| 240011485 | 240007689 | 1.64 | 59.75 | Curative (C) | 2017-06-24 | 2017-07-20 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | N | 240030529 | NOT MATCHED |